Form 4 for CC Chemours Co
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001062993-25-004721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-05 | 2025-03-03 | CC | Gumpel Damian | See Remarks | A - Grant | $0.00 | +110.5K | 23.9K | New | $0 |
| DM | 2025-03-05 | 2025-03-03 | CC | Gumpel Damian | See Remarks | A - Grant | $0.00 | +162.0K | 79.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | A | A | 86,580 | $0.00 | 110,479 | D | — | — | (F2) RSU award scheduled to vest in three equal annual installments beginning on March 3, 2026. |
| 2 | Common | Common Stock | 2025-03-03 | A | A | 23,899 | $0.00 | 23,899 | D | — | — | (F1) Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-03-03 | A | A | 82,613 | $0.00 | 82,613 | D | $15.25 · — to 2035-03-03 | 82,613 Common Stock | (F4) Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. (F3) These options are scheduled to vest in three equal annual installments beginning on March 3, 2026. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-03 | A | A | 79,436 | $0.00 | 79,436 | D | $13.86 · — to 2035-03-03 | 79,436 Common Stock | (F3) These options are scheduled to vest in three equal annual installments beginning on March 3, 2026. |